Variant report

Variant	esv1830977
Chromosome Location	chr5:68815501-68850642
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr5:68823022-68823295	K562	blood:	n/a	n/a
2	BRCA1	chr5:68816958-68817475	Hela-S3	cervix:	n/a	n/a
3	CBX3	chr5:68816862-68817461	HCT-116	colon:	n/a	n/a
4	CEBPB	chr5:68818550-68818697	Hela-S3	cervix:	n/a	chr5:68818610-68818621
5	CEBPB	chr5:68823244-68823535	HepG2	liver:	n/a	n/a
6	CEBPB	chr5:68818531-68818660	HepG2	liver:	n/a	chr5:68818610-68818621
7	CEBPB	chr5:68816638-68816772	HepG2	liver:	n/a	chr5:68816730-68816741
8	CEBPB	chr5:68817035-68817420	MCF-7	breast:	n/a	n/a
9	CEBPB	chr5:68816583-68816872	A549	lung:	n/a	chr5:68816730-68816741
10	CEBPB	chr5:68816572-68817603	Hela-S3	cervix:	n/a	chr5:68816730-68816741
11	CEBPB	chr5:68816523-68816910	MCF-7	breast:	n/a	chr5:68816730-68816741
12	CEBPB	chr5:68818510-68818663	A549	lung:	n/a	chr5:68818610-68818621
13	CEBPB	chr5:68823171-68823667	MCF-7	breast:	n/a	n/a
14	CEBPB	chr5:68816404-68817622	HCT-116	colon:	n/a	chr5:68816730-68816741
15	CEBPB	chr5:68816651-68816848	K562	blood:	n/a	chr5:68816730-68816741
16	CEBPB	chr5:68823188-68823480	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr5:68834723-68834923	HepG2	liver:	n/a	n/a
18	CEBPB	chr5:68823192-68823535	K562	blood:	n/a	n/a
19	CEBPB	chr5:68821436-68821696	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr5:68823233-68823538	IMR90	lung:	n/a	n/a
21	CEBPB	chr5:68816973-68817429	A549	lung:	n/a	n/a
22	CEBPB	chr5:68818514-68818731	MCF-7	breast:	n/a	chr5:68818610-68818621
23	CEBPB	chr5:68834691-68834785	HepG2	liver:	n/a	n/a
24	CEBPB	chr5:68818525-68818803	IMR90	lung:	n/a	chr5:68818610-68818621
25	CEBPB	chr5:68823197-68823519	K562	blood:	n/a	n/a
26	CEBPB	chr5:68816579-68817601	IMR90	lung:	n/a	chr5:68816730-68816741
27	CEBPB	chr5:68823213-68823538	A549	lung:	n/a	n/a
28	CEBPB	chr5:68823181-68823660	MCF-7	breast:	n/a	n/a
29	CEBPB	chr5:68823245-68823491	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr5:68816622-68817601	HCT-116	colon:	n/a	chr5:68816730-68816741
31	CTCF	chr5:68815840-68815919	GM10266	blood:	n/a	n/a
32	CTCF	chr5:68833712-68833842	LNCaP	prostate:	n/a	n/a
33	CTCF	chr5:68833676-68833858	LNCaP	prostate:	n/a	n/a
34	CTCF	chr5:68833712-68833856	Pancreas_OC	pancreas:	n/a	n/a
35	CTCF	chr5:68833702-68833774	Hela-S3	cervix:	n/a	n/a
36	CTCF	chr5:68838439-68838481	GM20000	blood:	n/a	n/a
37	CTCF	chr5:68838421-68838427	GM20000	blood:	n/a	n/a
38	CTCF	chr5:68816909-68817027	Lung_OC	lung:	n/a	n/a
39	CTCF	chr5:68833553-68833648	GM10266	blood:	n/a	n/a
40	E2F4	chr5:68819154-68819354	MCF10A-Er-Src	breast:	n/a	n/a
41	E2F4	chr5:68818457-68818607	MCF10A-Er-Src	breast:	n/a	n/a
42	ELF1	chr5:68816533-68816824	K562	blood:	n/a	n/a
43	EP300	chr5:68823661-68824329	ECC-1	luminal epithelium:	n/a	n/a
44	EP300	chr5:68816770-68817400	Hela-S3	cervix:	n/a	n/a
45	EP300	chr5:68823857-68824255	T-47D	breast:	n/a	n/a
46	EP300	chr5:68817058-68817154	K562	blood:	n/a	n/a
47	EP300	chr5:68823743-68824277	T-47D	breast:	n/a	n/a
48	EP300	chr5:68817003-68817202	SK-N-SH_RA	brain:	n/a	n/a
49	EP300	chr5:68816869-68817255	SK-N-SH_RA	brain:	n/a	n/a
50	EP300	chr5:68823783-68824405	MCF-7	breast:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:68711082..68712894-chr5:68825364..68828331,2	MCF-7	breast:
2	chr5:68811437..68815245-chr5:68822688..68826346,4	MCF-7	breast:
3	chr5:68791729..68794377-chr5:68827769..68829901,2	MCF-7	breast:
4	chr5:68813539..68815320-chr5:68820921..68822712,2	MCF-7	breast:
5	chr5:68820102..68821620-chr5:68821807..68823888,2	MCF-7	breast:
6	chr5:68664276..68666679-chr5:68812958..68815555,2	MCF-7	breast:
7	chr5:68786843..68790127-chr5:68821932..68828319,7	MCF-7	breast:
8	chr5:68820102..68821620-chr5:68821807..68823888,2	MCF-7	breast:
9	chr5:68787211..68792044-chr5:68819088..68825852,9	MCF-7	breast:

Variant related genes	Relation type
ENSG00000238740	TF binding region
OCLN	TF binding region
RNU6-724P	TF binding region
ENSG00000085231	chromatin interactions
ENSG00000152939	chromatin interactions
ENSG00000152942	chromatin interactions
ENSG00000197822	chromatin interactions

Extended variants
information (count: 633 )
Associated
traits (count: 109 )

Variant overlapped rSNPs/rCNVs (count:633 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs112310732	chr5:68815598-68815599	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs549892353	chr5:68815604-68815605	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs368139259	chr5:68815697-68815698	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs370294842	chr5:68815702-68815703	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs528886381	chr5:68815778-68815779	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs538100891	chr5:68815801-68815802	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs534731662	chr5:68815817-68815818	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs142483472	chr5:68815826-68815827	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs111707362	chr5:68815868-68815869	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs559576313	chr5:68815872-68815873	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs551981550	chr5:68815873-68815874	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs533363401	chr5:68815877-68815878	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs537188032	chr5:68815920-68815921	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs555448266	chr5:68815942-68815943	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs185506631	chr5:68815945-68815946	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs188077055	chr5:68815985-68815986	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs553058244	chr5:68816016-68816017	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs572338836	chr5:68816044-68816045	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs111743529	chr5:68816057-68816058	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs151298461	chr5:68816060-68816061	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs564313336	chr5:68816127-68816128	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs368103426	chr5:68816169-68816170	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs192067259	chr5:68816180-68816181	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs552939156	chr5:68816227-68816228	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs543597100	chr5:68816246-68816247	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs561790753	chr5:68816314-68816315	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs114091118	chr5:68816360-68816361	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs547406343	chr5:68816362-68816363	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs559066744	chr5:68816405-68816406	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs201666583	chr5:68816435-68816436	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs199996609	chr5:68816437-68816438	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs150318151	chr5:68816516-68816517	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs571253135	chr5:68816544-68816545	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs28659922	chr5:68816552-68816553	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs531010592	chr5:68816585-68816586	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs549136529	chr5:68816639-68816640	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs189128425	chr5:68816706-68816707	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs534793401	chr5:68816731-68816732	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs553359806	chr5:68816736-68816737	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs551529051	chr5:68816749-68816750	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs563657207	chr5:68816939-68816940	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs146460345	chr5:68817019-68817020	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs558088610	chr5:68817021-68817022	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs576377472	chr5:68817058-68817059	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs181104359	chr5:68817077-68817078	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs555587705	chr5:68817096-68817097	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs184924975	chr5:68817142-68817143	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs557127342	chr5:68817143-68817144	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs189135243	chr5:68817157-68817158	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs181088074	chr5:68817188-68817189	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:109)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ovarian cancer	21781307	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17133270	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
abnormal development	18461090	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	21045282	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelodysplastic syndrome	18663149	CNVD
Spinal muscular atrophy	15981080	CNVD
Spinal muscular atrophy	18839960	CNVD
Spinal muscular atrophy	19716110	CNVD
Sezary syndrome	18413736	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21990379	CNVD
Hirschsprung''s Disease	21712996	CNVD
Apoptosis	19488400	CNVD
Breast cancer	22048815	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Acute monocytic leukemia	16498392	CNVD
Colorectal cancer	20459617	CNVD
Gastric adenocarcinoma	19115996	CNVD
Spinal muscular atrophy	17160897	CNVD
Spinal muscular atrophy	17668391	CNVD
Spinal muscular atrophy	17668395	CNVD
Glioblastoma multiforme	22286061	CNVD
craniofacial dysmorphism	21918468	CNVD
Multiple myeloma	16616336	CNVD
Prostate cancer	16461572	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Pseudo-TORCH syndrome	20727516	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:290 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:68790200-68824600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr5:68799000-68823200	Weak transcription	Placenta	Placenta
3	chr5:68799400-68821800	Weak transcription	Fetal Stomach	stomach
4	chr5:68805600-68816400	Weak transcription	GM12878-XiMat	blood
5	chr5:68805600-68821600	Weak transcription	Lung	lung
6	chr5:68805600-68823400	Weak transcription	H9 Cell Line	embryonic stem cell
7	chr5:68805600-68826200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
8	chr5:68805600-68826600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr5:68806000-68824200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
10	chr5:68806400-68826400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
11	chr5:68806800-68816800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
12	chr5:68806800-68821400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
13	chr5:68807000-68821400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr5:68807000-68821600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr5:68809200-68816400	Weak transcription	NHEK	skin
16	chr5:68809200-68817000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
17	chr5:68809600-68817200	Weak transcription	NHLF	lung
18	chr5:68809800-68816600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr5:68810400-68815600	Weak transcription	HUES48 Cell Line	embryonic stem cell
20	chr5:68810400-68815600	Weak transcription	HUES6 Cell Line	embryonic stem cell
21	chr5:68810400-68821600	Weak transcription	H1 Cell Line	embryonic stem cell
22	chr5:68810400-68821800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
23	chr5:68810400-68823600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
24	chr5:68812200-68818000	Enhancers	Stomach Mucosa	stomach
25	chr5:68812400-68815600	Enhancers	Fetal Intestine Large	intestine
26	chr5:68812400-68816000	Enhancers	Liver	Liver
27	chr5:68812600-68815800	Enhancers	HepG2	liver
28	chr5:68812600-68818000	Enhancers	Rectal Mucosa Donor 31	rectum
29	chr5:68813400-68816600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr5:68813800-68816800	Weak transcription	HMEC	breast
31	chr5:68814000-68816400	Weak transcription	NH-A	brain
32	chr5:68814000-68816800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr5:68814000-68823400	Weak transcription	Fetal Lung	lung
34	chr5:68814200-68815800	Enhancers	Colonic Mucosa	Colon
35	chr5:68814200-68816000	Enhancers	Sigmoid Colon	Sigmoid Colon
36	chr5:68814200-68816600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr5:68814400-68816200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr5:68814400-68816200	Weak transcription	HUVEC	blood vessel
39	chr5:68814400-68816600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr5:68814400-68817000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr5:68814400-68823600	Weak transcription	Small Intestine	intestine
42	chr5:68814600-68816400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr5:68814600-68816400	Weak transcription	Muscle Satellite Cultured Cells	--
44	chr5:68814600-68816800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr5:68814600-68816800	Enhancers	A549	lung
46	chr5:68814600-68817000	Enhancers	Pancreas	Pancrea
47	chr5:68814600-68822000	Weak transcription	Fetal Kidney	kidney
48	chr5:68814800-68816800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr5:68814800-68816800	Weak transcription	Rectal Mucosa Donor 29	rectum
50	chr5:68814800-68818000	Genic enhancers	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links